PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Divalproex Sodium Extended-Release Tablets USP | 250mg |
 |
100 |
68180-260-01 |
Depakote® ER |
AB |
Anti-Convulsant |
| Fosaprepitant Dimeglumine for Injection | 150mg |
|
5mL single-dose vial |
68180-690-01 |
Emend® |
AP |
Antiemetic |
| Lapatinib Tablets | 250 mg |
|
150 |
68180-0801-36 |
Tykerb® |
AB |
Antineoplastic Agent |
| Posaconazole Delayed-Release Tablets | 100mg |
 |
60 |
70748-0258-07 |
Noxafil® |
AB |
Antifungal |
| Penicillamine Tablets USP | 250 mg |
 |
100 |
70748-0153-01 |
Depen® |
AB |
Antirheumatic |
| Arformoterol Tartrate Inhalation Solution | 15mcg/2mL |
|
30 UD Vials |
70748-0257-30 |
Brovana® |
NA |
Long-acting beta agonists (LABAs) |
| Meloxicam Capsules | 5mg |
|
30 |
68180-188-06 |
Vivlodex® |
AB |
analgesic |
| Rufinamide Oral Suspension | 40 mg/mL |
 |
460ml |
68180-797-01 |
Banzel® |
AB |
Antiepileptic |
| Tiotropium Bromide Inhalation Powder Capsules | 18mcg / capsules |
 |
30 |
68180-964-12 |
Spiriva® HandiHaler® |
AB |
Anticholinergics |
| GaviLyte™-N | 420-111.20-1.48-5.72 gm |
 |
4 L |
43386-050-19 |
NuLYTELY® |
AA |
Hyperosmotic |
| DOXOrubicin Hydrochloride Liposome Injection | 20mg/10mL (2mg/mL) |
 |
(1) 10mL single-dose vial |
70748-339-01 |
Doxil® |
AB |
Chemotherapeutic Agents |
| Prednisolone Acetate Ophthalmic Suspension USP | 1% |
|
5ml |
70748-332-02 |
Pred Forte™ |
AB |
Ophthalmic Anti-Inflammatory Corticosteroid |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
